Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 1, 1999, Pages 201-206

  Grinspoon, Steven ^a   Corcoran, Colleen ^a   Rosenthal, Daniel ^a   Stanley, Takara ^a   Parlman, Kristin ^a   Costello, Madeline ^a   Treat, Michael ^a   Davis, Sheila ^a   Burrows, Belton ^b   Basgoz, Nesli ^a   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIDS RELATED COMPLEX; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION FUNCTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; PRIORITY JOURNAL; PROGNOSIS; WASTING SYNDROME; WEIGHT REDUCTION;

ADULT; BODY COMPOSITION; EXERCISE; HIV WASTING SYNDROME; HUMANS; MALE; MUSCLES; PROTEASE INHIBITORS;

EID: 0032901942     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.1.201     Document Type: Article

References (27)

1. 1. Kotler DP, Wang J, Pierson RN. 1985 Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr. 42:1255-1265.
2. 2. Kotler DP, Tiemey AR, Wang J, Pierson Jr RN. 1989 Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 50:444-447.
3. 3. Grinspoon S, Corcoran C, Askari H, et al. 1998 Effects of androgen administration in men with AIDS wasting: a randomized, placebo-controlled, trial. Ann Intern Med. 129:18-26.
4. 4. Schambelan M, Mulligan K, Grunfeld C, et al. 1996 Recombinant human growth hormone in patients with HIV-associated wasting. Ann Intern Med. 125:873-882.
5. 5. Bulcke JA, Termote JL, Palmers Y, Crolla D. 1979 Computed tomography of the human skeletal muscular system. Neuroradiology. 17:127-136.
6. 6. Maughan RJ, Watson JS, Weir J. 1983 Strength and cross-sectional muscle area of human skeletal muscle. J Physiol. 338:37-49.
7. 7. Centers for Disease Control. 1987 Revision of the CDC surveillance definition for acquired immunodeficiency syndrome. Morbidity and Mortality Weekly Report. 36-3S-15S.
8. 8. Mazess RB, Barden HS, Bisek JP, Hanson J. 1990 Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr. 51:1106-1112.
9. 9. Forbes GB, Lewis AM. 1956 Total sodium, potassium and chloride in adult man. J Clin Invest. 35:596-600.
10. 10. Mendez J, Buskirk ER. 1971 Creatinine-height index. Am J Clin Nutr. 24:385-386.
11. 11. Heymsfield SB, Arteaga C, McMannus C, Smith J, Moffitt S. 1983 Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr. 37:478-494.
12. 12 Metropolitan Life Insurance Co. 1983 Height and weight tables. Stat Bull. 64:2-9.
13. 13 Karnofsky DA, Abelman WH, Craver LF, Burchenal JH. 1948 The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer. 1:634-656.
14. 14 Kohl HW, Blair SN, Paffenberger RS, Macera CA, Kronenfeld JJ. 1988 A mail survey of physical activity habits as related to measured physical fitness. Am J Epidemiol. 127:1228-1239.
15. 15. Guyatt GH, Thompson PJ, Berman LB, et al. 1985 How should we measure function in patients with chronic heart and lung disease. J Chronic Dis. 38:517-524.
16. 16. National Isometric Muscle Strength (NIMS) Database Consortium. 1996 Muscular weakness assessment: use of normal isometric strength data. Arch Phys Med Rehabil. 77:1251-1255.
17. 17. Munsat TL, Andres PL, Skerry LM. 1989 Quantitative assessment of deficit in amyotrophic lateral sclerosis. Physical Medicine and Rehabilitation: State of the Art Reviews. 3:188-193.
18. 18. Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL. 1986 Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology. 36:937-941.
19. 19. Jordan CD, Flood JG, Laposata M, Lewandrowski KB. 1992 Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values. N Engl J Med. 327:718-724.
20. 20. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. 1992 Quality of life in persons with human immunodeficiency virus infection: measurement by the medical outcomes study instrument. Ann Intern Med. 116:129-137.
21. 21. Abrams DI, Goldman AI, Launer C, et al. 1994 A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. N Engl J Med. 330:657-662.
22. 22. Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller MJ. 1995 Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquired Immune Defic Syndr. 8:239-246.
23. 23. Grinspoon S, Corcoran C, Lee K, et al. 1996 Loss of lean body mass and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab. 81:4051-4058.
24. 24. Minotti JR, Pillay P, Oka R, Wells L, Christoph I, Massie BM. 1993 Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol. 75:373-381.
25. 25. Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Fallon J. 1998 Visceral abdominal-fat accumulation associated with use of indinavir. Lancet. 351:871-875.
26. 26. Miller KM, Daly PA, Sentochnik D, et al. 1997 Pseudo-Cushing's syndrome in HIV-infected men. Clin Infect Dis. 27:68-72.
27. 27. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. 1998 "Buffalo hump" in men with HIV-I infection. Lancet. 351:867-870.